• 环保意识的提升促使消费者更倾向于购买可持续产品。
  • 自动化和机器人技术在提高制造业效率和安全性方面发挥着关键作用。
  • 气候变化导致的极端天气事件频发,促使国际社会加强应对气候变化的合作。
  • 大数据和机器学习在商业决策中的作用日益凸显。
  • 生物技术在医药领域的应用为治疗复杂疾病提供了新的可能性。
  • 大数据在商业决策和市场预测中的作用日益凸显。
  • 随着人们对隐私保护的关注增加,数据安全成为企业必须重视的问题。
  • 教育公平是社会进步的基石。
  • 在线教育平台的兴起为传统教育模式带来了挑战和机遇。
  • 随着全球健康危机的持续,心理健康问题成为社会关注的焦点。
  • 移动支付的普及正在改变消费者的支付习惯。
  • 随着人口老龄化的加剧,养老服务和健康管理需求日益增长。
  • 在线教育的普及使得知识获取更加便捷,但也引发了公平性问题。
  • 电动汽车的快速增长正在推动传统汽车行业的转型。
  • 移动支付和数字货币正在逐渐取代传统支付方式。
  • 大数据和机器学习在商业智能和市场分析中发挥关键作用。
  • 生物多样性的保护成为全球环境政策的重点。
  • 在线健身和虚拟健身课程在疫情期间迅速流行。
  • 大数据在商业分析和市场预测中发挥着关键作用。
  • 数字货币市场的波动性吸引了投资者和监管机构的注意。
  • 电子商务的快速发展改变了消费者的购物习惯。
  • 随着自动驾驶技术的发展,交通系统的变革指日可待。
  • 太空探索的商业化为航天行业带来了新的机遇。
  • 随着人工智能技术的不断进步,机器学习正在成为教育领域的新趋势。
  • 生物技术在医药领域的应用带来了新的突破和挑战。
  • Human microbiota alterations — emerging predictors of renal diseases and kidney-specific aging | Pan | Aging Pathobiology and Therapeutics

    Human microbiota alterations — emerging predictors of renal diseases and kidney-specific aging

    Miaomiao Pan, Ming Zhang, Xingyu Rong, Chao Zhao

    Abstract


    Rapid advances in sequencing and analytical technologies have increased our understanding of the interactions between the microbiome and the host. The microbiome plays a variety of physiological roles in the health of the host and pathological roles in disease; for example, the microbiome changes significantly when kidney health is compromised and during kidney-specific aging. At present, good diagnostic markers are absent for early renal injury. However, the composition of the microbiome could provide useful indications for disease diagnosis and treatment beyond more conventional diagnostic markers. Such indications are well represented in chronic kidney disease, immunoglobulin A nephropathy, idiopathic nephrotic syndrome, and diabetic nephropathy. With sensitivity, specificity, and stability, the microbiota can provide more possibilities for the diagnosis of the early recognition of asymptomatic renal injury and aging. Moreover, probiotics and microbial metabolites have shown beneficial effects in the treatment of kidney diseases. Therapeutic measures targeting the microbiota can effectively improve the immune response and inflammatory state of the body. This paper reviews the current evidence on how the microbiome is not only a potentially effective tool for clinical diagnosis but also an important focus for the study of kidney disease and aging.
    Keywords: Human microbiota, kidney-specific aging, renal disease, high-throughput sequencing, predictor




    Subscribe to receive issue release notifications
    and newsletters from journals